Atlas Trials

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet

Clinical trial NCT05450575 · COMPLETED

Trial details

NCT number
NCT05450575
Sponsor
Hanmi Pharmaceutical Company Limited
Status
COMPLETED
Study type
OBSERVATIONAL
HypertensionDyslipidemia
Start date
2018-04-17
Primary completion
2021-07-20
Enrollment
5400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.